David Lamond Purchases 33,500 Shares of Applied Molecular Transport Inc. (NASDAQ:AMTI) Stock

Applied Molecular Transport Inc. (NASDAQ:AMTIGet Rating) Director David Lamond purchased 33,500 shares of the firm’s stock in a transaction dated Monday, May 23rd. The stock was acquired at an average cost of $3.26 per share, for a total transaction of $109,210.00. Following the completion of the purchase, the director now owns 1,077,519 shares of the company’s stock, valued at approximately $3,512,711.94. The acquisition was disclosed in a filing with the SEC, which is available at this link.

David Lamond also recently made the following trade(s):

  • On Friday, May 20th, David Lamond purchased 33,000 shares of Applied Molecular Transport stock. The stock was acquired at an average cost of $3.08 per share, for a total transaction of $101,640.00.

Shares of AMTI traded up $0.07 during trading on Monday, reaching $3.25. 216,452 shares of the company traded hands, compared to its average volume of 336,501. Applied Molecular Transport Inc. has a twelve month low of $3.01 and a twelve month high of $52.71. The stock has a market cap of $125.63 million, a PE ratio of -1.02 and a beta of 1.93. The stock has a 50-day simple moving average of $5.53 and a 200-day simple moving average of $9.86.

Applied Molecular Transport (NASDAQ:AMTIGet Rating) last announced its quarterly earnings data on Monday, May 9th. The company reported ($1.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.75) by ($0.35). Sell-side analysts predict that Applied Molecular Transport Inc. will post -3.32 EPS for the current fiscal year.

Several hedge funds have recently made changes to their positions in AMTI. Quantbot Technologies LP grew its holdings in Applied Molecular Transport by 371.4% during the 1st quarter. Quantbot Technologies LP now owns 6,600 shares of the company’s stock worth $49,000 after acquiring an additional 5,200 shares in the last quarter. State Street Corp grew its holdings in Applied Molecular Transport by 6.6% during the 1st quarter. State Street Corp now owns 456,271 shares of the company’s stock worth $3,431,000 after acquiring an additional 28,432 shares in the last quarter. Renaissance Technologies LLC grew its holdings in Applied Molecular Transport by 146.7% during the 1st quarter. Renaissance Technologies LLC now owns 428,200 shares of the company’s stock worth $3,220,000 after acquiring an additional 254,600 shares in the last quarter. EPIQ Capital Group LLC grew its holdings in Applied Molecular Transport by 0.3% during the 1st quarter. EPIQ Capital Group LLC now owns 9,098,780 shares of the company’s stock worth $68,423,000 after acquiring an additional 23,292 shares in the last quarter. Finally, Ergoteles LLC grew its holdings in Applied Molecular Transport by 53.0% during the 1st quarter. Ergoteles LLC now owns 17,404 shares of the company’s stock worth $131,000 after acquiring an additional 6,031 shares in the last quarter. Hedge funds and other institutional investors own 71.34% of the company’s stock.

A number of equities analysts have commented on AMTI shares. JMP Securities reduced their target price on shares of Applied Molecular Transport from $86.00 to $50.00 and set a “market outperform” rating on the stock in a research note on Thursday. SVB Leerink dropped their price target on shares of Applied Molecular Transport from $60.00 to $21.00 and set an “outperform” rating for the company in a research report on Friday.

About Applied Molecular Transport (Get Rating)

Applied Molecular Transport Inc, a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications.

Featured Stories

Insider Buying and Selling by Quarter for Applied Molecular Transport (NASDAQ:AMTI)

Receive News & Ratings for Applied Molecular Transport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Molecular Transport and related companies with MarketBeat.com's FREE daily email newsletter.